Cargando…

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Singanayagam, Anika, Hakki, Seran, Dunning, Jake, Madon, Kieran J, Crone, Michael A, Koycheva, Aleksandra, Derqui-Fernandez, Nieves, Barnett, Jack L, Whitfield, Michael G, Varro, Robert, Charlett, Andre, Kundu, Rhia, Fenn, Joe, Cutajar, Jessica, Quinn, Valerie, Conibear, Emily, Barclay, Wendy, Freemont, Paul S, Taylor, Graham P, Ahmad, Shazaad, Zambon, Maria, Ferguson, Neil M, Lalvani, Ajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554486/
https://www.ncbi.nlm.nih.gov/pubmed/34756186
http://dx.doi.org/10.1016/S1473-3099(21)00648-4
_version_ 1784591810776006656
author Singanayagam, Anika
Hakki, Seran
Dunning, Jake
Madon, Kieran J
Crone, Michael A
Koycheva, Aleksandra
Derqui-Fernandez, Nieves
Barnett, Jack L
Whitfield, Michael G
Varro, Robert
Charlett, Andre
Kundu, Rhia
Fenn, Joe
Cutajar, Jessica
Quinn, Valerie
Conibear, Emily
Barclay, Wendy
Freemont, Paul S
Taylor, Graham P
Ahmad, Shazaad
Zambon, Maria
Ferguson, Neil M
Lalvani, Ajit
author_facet Singanayagam, Anika
Hakki, Seran
Dunning, Jake
Madon, Kieran J
Crone, Michael A
Koycheva, Aleksandra
Derqui-Fernandez, Nieves
Barnett, Jack L
Whitfield, Michael G
Varro, Robert
Charlett, Andre
Kundu, Rhia
Fenn, Joe
Cutajar, Jessica
Quinn, Valerie
Conibear, Emily
Barclay, Wendy
Freemont, Paul S
Taylor, Graham P
Ahmad, Shazaad
Zambon, Maria
Ferguson, Neil M
Lalvani, Ajit
author_sort Singanayagam, Anika
collection PubMed
description BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. METHODS: Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. We analysed transmission risk by vaccination status for 231 contacts exposed to 162 epidemiologically linked delta variant-infected index cases. We compared viral load trajectories from fully vaccinated individuals with delta infection (n=29) with unvaccinated individuals with delta (n=16), alpha (B.1.1.7; n=39), and pre-alpha (n=49) infections. Primary outcomes for the epidemiological analysis were to assess the secondary attack rate (SAR) in household contacts stratified by contact vaccination status and the index cases’ vaccination status. Primary outcomes for the viral load kinetics analysis were to detect differences in the peak viral load, viral growth rate, and viral decline rate between participants according to SARS-CoV-2 variant and vaccination status. FINDINGS: The SAR in household contacts exposed to the delta variant was 25% (95% CI 18–33) for fully vaccinated individuals compared with 38% (24–53) in unvaccinated individuals. The median time between second vaccine dose and study recruitment in fully vaccinated contacts was longer for infected individuals (median 101 days [IQR 74–120]) than for uninfected individuals (64 days [32–97], p=0·001). SAR among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% [95% CI 15–35] for vaccinated vs 23% [15–31] for unvaccinated). 12 (39%) of 31 infections in fully vaccinated household contacts arose from fully vaccinated epidemiologically linked index cases, further confirmed by genomic and virological analysis in three index case–contact pairs. Although peak viral load did not differ by vaccination status or variant type, it increased modestly with age (difference of 0·39 [95% credible interval –0·03 to 0·79] in peak log(10) viral load per mL between those aged 10 years and 50 years). Fully vaccinated individuals with delta variant infection had a faster (posterior probability >0·84) mean rate of viral load decline (0·95 log(10) copies per mL per day) than did unvaccinated individuals with pre-alpha (0·69), alpha (0·82), or delta (0·79) variant infections. Within individuals, faster viral load growth was correlated with higher peak viral load (correlation 0·42 [95% credible interval 0·13 to 0·65]) and slower decline (–0·44 [–0·67 to –0·18]). INTERPRETATION: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Host–virus interactions early in infection may shape the entire viral trajectory. FUNDING: National Institute for Health Research.
format Online
Article
Text
id pubmed-8554486
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Science ;, The Lancet Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-85544862021-10-29 Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study Singanayagam, Anika Hakki, Seran Dunning, Jake Madon, Kieran J Crone, Michael A Koycheva, Aleksandra Derqui-Fernandez, Nieves Barnett, Jack L Whitfield, Michael G Varro, Robert Charlett, Andre Kundu, Rhia Fenn, Joe Cutajar, Jessica Quinn, Valerie Conibear, Emily Barclay, Wendy Freemont, Paul S Taylor, Graham P Ahmad, Shazaad Zambon, Maria Ferguson, Neil M Lalvani, Ajit Lancet Infect Dis Articles BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. METHODS: Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. We analysed transmission risk by vaccination status for 231 contacts exposed to 162 epidemiologically linked delta variant-infected index cases. We compared viral load trajectories from fully vaccinated individuals with delta infection (n=29) with unvaccinated individuals with delta (n=16), alpha (B.1.1.7; n=39), and pre-alpha (n=49) infections. Primary outcomes for the epidemiological analysis were to assess the secondary attack rate (SAR) in household contacts stratified by contact vaccination status and the index cases’ vaccination status. Primary outcomes for the viral load kinetics analysis were to detect differences in the peak viral load, viral growth rate, and viral decline rate between participants according to SARS-CoV-2 variant and vaccination status. FINDINGS: The SAR in household contacts exposed to the delta variant was 25% (95% CI 18–33) for fully vaccinated individuals compared with 38% (24–53) in unvaccinated individuals. The median time between second vaccine dose and study recruitment in fully vaccinated contacts was longer for infected individuals (median 101 days [IQR 74–120]) than for uninfected individuals (64 days [32–97], p=0·001). SAR among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% [95% CI 15–35] for vaccinated vs 23% [15–31] for unvaccinated). 12 (39%) of 31 infections in fully vaccinated household contacts arose from fully vaccinated epidemiologically linked index cases, further confirmed by genomic and virological analysis in three index case–contact pairs. Although peak viral load did not differ by vaccination status or variant type, it increased modestly with age (difference of 0·39 [95% credible interval –0·03 to 0·79] in peak log(10) viral load per mL between those aged 10 years and 50 years). Fully vaccinated individuals with delta variant infection had a faster (posterior probability >0·84) mean rate of viral load decline (0·95 log(10) copies per mL per day) than did unvaccinated individuals with pre-alpha (0·69), alpha (0·82), or delta (0·79) variant infections. Within individuals, faster viral load growth was correlated with higher peak viral load (correlation 0·42 [95% credible interval 0·13 to 0·65]) and slower decline (–0·44 [–0·67 to –0·18]). INTERPRETATION: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Host–virus interactions early in infection may shape the entire viral trajectory. FUNDING: National Institute for Health Research. Elsevier Science ;, The Lancet Pub. Group 2022-02 /pmc/articles/PMC8554486/ /pubmed/34756186 http://dx.doi.org/10.1016/S1473-3099(21)00648-4 Text en © 2021 The Author(s). Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Singanayagam, Anika
Hakki, Seran
Dunning, Jake
Madon, Kieran J
Crone, Michael A
Koycheva, Aleksandra
Derqui-Fernandez, Nieves
Barnett, Jack L
Whitfield, Michael G
Varro, Robert
Charlett, Andre
Kundu, Rhia
Fenn, Joe
Cutajar, Jessica
Quinn, Valerie
Conibear, Emily
Barclay, Wendy
Freemont, Paul S
Taylor, Graham P
Ahmad, Shazaad
Zambon, Maria
Ferguson, Neil M
Lalvani, Ajit
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title_full Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title_fullStr Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title_full_unstemmed Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title_short Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
title_sort community transmission and viral load kinetics of the sars-cov-2 delta (b.1.617.2) variant in vaccinated and unvaccinated individuals in the uk: a prospective, longitudinal, cohort study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554486/
https://www.ncbi.nlm.nih.gov/pubmed/34756186
http://dx.doi.org/10.1016/S1473-3099(21)00648-4
work_keys_str_mv AT singanayagamanika communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT hakkiseran communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT dunningjake communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT madonkieranj communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT cronemichaela communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT koychevaaleksandra communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT derquifernandeznieves communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT barnettjackl communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT whitfieldmichaelg communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT varrorobert communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT charlettandre communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT kundurhia communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT fennjoe communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT cutajarjessica communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT quinnvalerie communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT conibearemily communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT barclaywendy communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT freemontpauls communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT taylorgrahamp communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT ahmadshazaad communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT zambonmaria communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT fergusonneilm communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT lalvaniajit communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy
AT communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy